Related Experiment Videos
Severe myoclonic epilepsy in infancy: evolution of electroencephalographic and clinical features
1Department of Pediatrics, National Taiwan University Hospital, Taipei, R.O.C.
Insights
Severe myoclonic epilepsy in infancy (SMEI) presents with challenging seizures and neurodevelopmental decline. A combination of valproic acid, clonazepam, and carbamazepine showed promise in managing diverse seizure types in affected children.
Area of Science:
- Pediatric Neurology
- Epileptology
- Clinical Neuroscience
Background:
- Severe myoclonic epilepsy in infancy (SMEI) is a rare and severe form of epilepsy characterized by specific seizure types and developmental regression.
- Early diagnosis and understanding of SMEI's complex presentation are crucial for effective management.
- Patients with SMEI often exhibit drug-resistant epilepsy, necessitating exploration of combination therapies.
Purpose of the Study:
- To describe the clinical characteristics, EEG findings, and treatment outcomes of 10 patients diagnosed with SMEI.
- To evaluate the efficacy of a specific antiepileptic drug combination in managing the diverse seizure types observed in SMEI.
- To highlight the challenges in treating SMEI and identify areas for future research.
Main Methods:
- Retrospective analysis of 10 patients diagnosed with SMEI based on established diagnostic criteria.
- Detailed review of clinical history, seizure semiology, electroencephalographic (EEG) findings, and treatment responses.
- Assessment of the impact of comedication with valproic acid, clonazepam, and carbamazepine on seizure frequency and EEG abnormalities.
Main Results:
- All 10 patients presented with early-onset febrile seizures followed by myoclonic seizures, other seizure types, and neurodevelopmental deterioration.
- EEG studies revealed generalized and focal abnormalities, including spike-and-wave discharges and photosensitivity.
- Combination therapy with valproic acid, clonazepam, and carbamazepine led to a reduction in myoclonic seizures and atypical absences, with parallel EEG improvements in some patients.
- Partial seizures, secondarily generalized seizures, and status epilepticus remained challenging to control.
Conclusions:
- SMEI is a severe epilepsy syndrome with significant treatment resistance.
- Comedication of valproic acid, clonazepam, and carbamazepine appears to be a potentially effective strategy for managing the varied seizure manifestations in SMEI.
- Further research is warranted to elucidate the underlying etiology of SMEI and develop more effective therapeutic interventions.
Abstract:
Since 1987, we have diagnosed 10 patients, 4 males and 6 females, aged 2-11 years at the last evaluation, who all met the following criteria of severe myoclonic epilepsy in infancy (SMEI): generalized or unilateral long-lasting febrile clonic seizures in the first year of life; the subsequent appearance of myoclonic seizures and other types of seizure (partial seizures, atypical absences and convulsive status epilepticus); and neuropsychological deterioration for a certain period. Family histories of epilepsy and febrile seizures could be traced in 1 and 3 cases, respectively. None of them had previous personal history of brain insult. Electroencephalographic (EEGic) recordings in febrile seizure stage were normal; and continuous prophylaxis with phenobarbital failed to prevent the recurrence of febrile seizures. EEG studies in myoclonic stage showed generalized spike-and-waves, polyspike-and-waves, focal abnormalities and/or photosensitivity. The seizures were highly resistant to antiepileptic drugs. Our experiences suggested that comedication of valproic acid, clonazepam and carbamazepine may be most effective in treatment of the diverse seizures including myoclonic seizures, myoclonic-tonic-clonic seizures, atypical absences and partial seizures. Myoclonic seizures and atypical absences diminished in parallel to a clear-cut decrease in generalized abnormalities on EEG in 4 cases aged more than 7 years. However, the partial seizures, secondarily generalized seizures and status epilepticus were still present. Further investigations should aim to identify the underlying etiology and to search more effective treatment.